CN112933184A - Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof - Google Patents
Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof Download PDFInfo
- Publication number
- CN112933184A CN112933184A CN202110223108.7A CN202110223108A CN112933184A CN 112933184 A CN112933184 A CN 112933184A CN 202110223108 A CN202110223108 A CN 202110223108A CN 112933184 A CN112933184 A CN 112933184A
- Authority
- CN
- China
- Prior art keywords
- parts
- cerebrovascular diseases
- preparation
- root
- treating cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 33
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 33
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 33
- 239000003814 drug Substances 0.000 claims abstract description 43
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 26
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 14
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 14
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 14
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 14
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 14
- 239000004863 Frankincense Substances 0.000 claims abstract description 14
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 14
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims abstract description 14
- 241000405414 Rehmannia Species 0.000 claims abstract description 14
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 14
- 210000003056 antler Anatomy 0.000 claims abstract description 14
- 241001523681 Dendrobium Species 0.000 claims abstract description 13
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 13
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 13
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 13
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 13
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 13
- 235000011477 liquorice Nutrition 0.000 claims abstract description 13
- 244000081426 Ranunculus ficaria Species 0.000 claims abstract description 5
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 4
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 4
- 229940079593 drug Drugs 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 241001106477 Paeoniaceae Species 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 9
- 241001530126 Scrophularia Species 0.000 description 9
- 244000132619 red sage Species 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 206010031123 Orthopnoea Diseases 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 208000004327 Paroxysmal Dyspnea Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000012144 orthopnea Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and a preparation method thereof. The invention comprises the following components in parts by weight: 8-12 parts of pilose antler, 15-25 parts of prepared rehmannia root, 10-20 parts of platycladi seed, 10-20 parts of Chinese magnoliavine fruit, 10-20 parts of Chinese angelica, 10-20 parts of ligusticum wallichii, 10-20 parts of figwort root, 10-20 parts of frankincense, 10-20 parts of honeysuckle flower, 10-20 parts of pseudo-ginseng, 10-20 parts of white paeony root, 10-20 parts of salvia miltiorrhiza, 10-20 parts of dendrobium, 10-20 parts of cape jasmine fruit and 10-20 parts of liquorice. The invention combines the theories of traditional Chinese medicine such as the theory of yin and yang, the theory of channels and collaterals and the like, has scientific and reasonable compatibility, obvious curative effect on cardiovascular and cerebrovascular diseases, no side effect, convenient taking and economy.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and a preparation method thereof.
Background
Cardiovascular and cerebrovascular diseases are the general names for cardiovascular and cerebrovascular diseases. At present, cardiovascular and cerebrovascular diseases are diseases with high morbidity, high disability rate, high death rate, high recurrence rate, high medical expense and many complications in China. Cardiovascular and cerebrovascular diseases mainly refer to 11 diseases such as coronary heart disease, myocardial infarction, cerebral thrombosis, hypertension, etc., and are caused by hypertension, hyperlipemia, hyperglycemia, blood hyperviscosity, platelet function enhancement, arteriosclerosis, in vivo free radical content increase and microcirculation disturbance; the more blood fat is accumulated on the vessel wall, atherosclerosis is caused, the vessel lumen is narrow and small, the blood flow is blocked, substances such as nutrient components, oxygen and the like cannot be smoothly conveyed to the required part of a body, wastes such as carbon dioxide and the like cannot be sufficiently taken away, and the vessel wall is thinned, embrittled and loses elasticity.
In the conventional treatment method at present, the operation has higher risk and is easy to have complications; the commonly used medicines have great side effects, and many patients need to take the medicines for life, which brings great harm to the viscera organs such as intestines, stomachs, livers and kidneys, and the like, causes the functional decline of the body, and further causes a series of pathological changes. Therefore, a medicament which has obvious curative effect and small toxic and side effect and is suitable for long-term use is urgently needed in the market.
Disclosure of Invention
Aiming at the technical problems, the invention aims to provide the traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and the preparation method thereof, and the traditional Chinese medicine preparation has the advantages of obvious curative effect on the cardiovascular and cerebrovascular diseases, no side effect, convenient taking, economy and practicability.
In order to achieve the purpose, the invention adopts the following technical scheme:
a traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases comprises the following components in parts by weight: 8-12 parts of pilose antler, 15-25 parts of prepared rehmannia root, 10-20 parts of platycladi seed, 10-20 parts of Chinese magnoliavine fruit, 10-20 parts of Chinese angelica, 10-20 parts of ligusticum wallichii, 10-20 parts of figwort root, 10-20 parts of frankincense, 10-20 parts of honeysuckle flower, 10-20 parts of pseudo-ginseng, 10-20 parts of white paeony root, 10-20 parts of salvia miltiorrhiza, 10-20 parts of dendrobium, 10-20 parts of cape jasmine fruit and 10-20 parts of liquorice.
Further, the traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases comprises the following components in parts by mass: 8-10 parts of pilose antler, 18-22 parts of prepared rehmannia root, 12-18 parts of platycladi seed, 12-18 parts of Chinese magnoliavine fruit, 12-18 parts of Chinese angelica, 12-18 parts of ligusticum wallichii, 12-18 parts of figwort root, 12-18 parts of frankincense, 12-18 parts of honeysuckle flower, 12-18 parts of pseudo-ginseng, 12-18 parts of white paeony root, 12-18 parts of salvia miltiorrhiza, 12-18 parts of dendrobium, 12-18 parts of cape jasmine fruit and 12-18 parts of liquorice.
Preferably, the traditional Chinese medicine medicament for treating cardiovascular and cerebrovascular diseases comprises the following components in parts by mass: 10 parts of pilose antler, 20 parts of prepared rehmannia root, 15 parts of platycladi seed, 15 parts of Chinese magnoliavine fruit, 15 parts of Chinese angelica, 15 parts of ligusticum wallichii, 15 parts of figwort root, 15 parts of frankincense, 15 parts of honeysuckle, 15 parts of pseudo-ginseng, 15 parts of white paeony root, 15 parts of salvia miltiorrhiza, 15 parts of dendrobium, 15 parts of cape jasmine fruit and 15 parts of liquorice.
The preparation method of the traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases comprises the following steps:
(1) weighing the medicines according to the weight part ratio, and respectively drying the medicines;
(2) mixing and crushing the dried medicines, and sieving;
(3) adding honey into the medicinal powder, mixing, making into honeyed pill, and sealing for storage to obtain the Chinese medicinal preparation.
Further, the powder is sieved by a 120-mesh sieve with 100 meshes after being crushed in the step (2).
Further, the amount of the honey in the step (3) is 30-40% of the total mass of the medicine powder.
Compared with the prior art, the invention has the following beneficial effects:
the traditional Chinese medicine composition combines the theories of yin and yang, the theory of channels and collaterals and the like, has scientific and reasonable compatibility, has the effects of tonifying kidney and yang, tonifying kidney and nourishing essence, nourishing blood and yin, nourishing heart and soothing nerves, protecting liver and lowering enzyme, reinforcing kidney and tonifying qi, enriching blood and moistening dryness, activating blood and dissolving stasis, detoxifying and removing stasis, warming and activating vital energy and dissipating blood, dredging arthralgia and relieving pain, dissolving stasis and promoting tissue regeneration, regulating menstruation and regulating meridians, clearing heat and purging pathogenic fire, cooling blood and detoxifying and the like, has obvious treatment effect on cardiovascular and cerebrovascular diseases, has no side effect, is convenient to.
The invention relates to a traditional Chinese medicine preparation for treating insomnia, which has the following pharmacological effects by applying traditional Chinese medicines:
pilose antler: to tonify kidney, strengthen yang, tonify kidney and nourish essence.
Prepared rehmannia root: nourishing yin, nourishing essence and marrow, sweet in flavor, warm in nature, entering heart, liver and kidney meridians.
Arborvitae seed: nourish blood and tranquilize mind, nourish yin to relieve constipation, moisten intestines to relieve constipation.
Schisandra chinensis: invigorating spleen, replenishing qi, protecting liver, lowering transaminase, reinforcing kidney, and invigorating qi.
Chinese angelica: tonify blood, moisten dryness, regulate menstruation and alleviate pain.
Ligusticum wallichii: promoting blood circulation, removing blood stasis, dredging collaterals, and relieving pain.
Figwort root: clear heat, nourish yin, remove toxicity and dissipate nodulation.
Frankincense: pungent and warm herbs dispel heat, warm meridians and activate blood, move qi and relieve chest stuffiness, unblock arthralgia and alleviate pain.
Honeysuckle flower: clear heat and remove toxicity, cool blood and relieve swelling.
Pseudo-ginseng: clearing away heat, lowering blood pressure, relieving swelling, relieving pain, removing blood stasis, and stopping bleeding.
White peony root: nourish blood and regulate blood, soften liver and alleviate pain.
Red sage root: promoting blood circulation, removing blood stasis, dredging collaterals, relieving pain, regulating menstruation, and regulating pulse.
Dendrobe: nourish yin and nourish stomach, clear heat and promote fluid production.
Gardenia: clear heat and purge fire, cool blood and remove toxicity.
Licorice root: harmonize the drugs.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The materials used in the following examples are all commercially available from conventional sources.
Example 1
A traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases comprises the following components in parts by weight: 8 parts of pilose antler, 25 parts of prepared rehmannia root, 10 parts of platycladi seed, 20 parts of Chinese magnoliavine fruit, 10 parts of Chinese angelica, 10 parts of ligusticum wallichii, 20 parts of figwort root, 20 parts of frankincense, 10 parts of honeysuckle flower, 20 parts of pseudo-ginseng, 10 parts of white paeony root, 10 parts of salvia miltiorrhiza, 20 parts of dendrobium, 20 parts of cape jasmine fruit and 10 parts of liquorice.
Example 2
A traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases comprises the following components in parts by weight: 12 parts of pilose antler, 15 parts of prepared rehmannia root, 20 parts of platycladi seed, 10 parts of Chinese magnoliavine fruit, 20 parts of Chinese angelica, 20 parts of ligusticum wallichii, 10 parts of figwort root, 10 parts of frankincense, 20 parts of honeysuckle flower, 10 parts of pseudo-ginseng, 20 parts of white paeony root, 20 parts of salvia miltiorrhiza, 10 parts of dendrobium, 10 parts of cape jasmine fruit and 20 parts of liquorice.
Example 3
A traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases comprises the following components in parts by weight: 10 parts of pilose antler, 18 parts of prepared rehmannia root, 18 parts of platycladi seed, 12 parts of Chinese magnoliavine fruit, 12 parts of Chinese angelica, 18 parts of ligusticum wallichii, 18 parts of figwort root, 18 parts of frankincense, 12 parts of honeysuckle flower, 12 parts of pseudo-ginseng, 12 parts of white paeony root, 18 parts of salvia miltiorrhiza, 12 parts of dendrobium, 18 parts of cape jasmine fruit and 12 parts of liquorice.
Example 4
A traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases comprises the following components in parts by weight: 8 parts of pilose antler, 22 parts of prepared rehmannia root, 12 parts of platycladi seed, 18 parts of Chinese magnoliavine fruit, 18 parts of Chinese angelica, 12 parts of ligusticum wallichii, 12 parts of figwort root, 12 parts of frankincense, 18 parts of honeysuckle, 18 parts of pseudo-ginseng, 18 parts of white paeony root, 12 parts of salvia miltiorrhiza, 18 parts of dendrobium, 12 parts of cape jasmine fruit and 18 parts of liquorice.
Example 5
A traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases comprises the following components in parts by weight: 10 parts of pilose antler, 20 parts of prepared rehmannia root, 15 parts of platycladi seed, 15 parts of Chinese magnoliavine fruit, 15 parts of Chinese angelica, 15 parts of ligusticum wallichii, 15 parts of figwort root, 15 parts of frankincense, 15 parts of honeysuckle, 15 parts of pseudo-ginseng, 15 parts of white paeony root, 15 parts of salvia miltiorrhiza, 15 parts of dendrobium, 15 parts of cape jasmine fruit and 15 parts of liquorice.
Preparation example
The preparation method of the traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases in the above embodiments 1 to 5 comprises the following steps:
(1) weighing the medicines according to the weight part ratio, and drying the medicines by a dryer respectively;
(2) crushing the dried medicine mixture by a crusher and then sieving the crushed medicine mixture by a sieve of 100-120 meshes;
(3) adding 30-40% of honey into the medicinal powder, making into honeyed pill, and sealing for storage.
The beneficial effects of the invention are specifically illustrated below in combination with clinical experimental data:
1. general data
The inventor randomly selects 50 patients with cardiovascular and cerebrovascular diseases from 3 months to 4 months in 2018 to obtain the traditional Chinese medicine composition.
2. Test method
2.1 methods of treatment
A patient orally takes the traditional Chinese medicine preparation prepared according to the embodiment 5, 50mg is taken each time, twice a day in the morning and at night, 10 days are taken as a treatment course, and 6 treatment courses are continuously taken.
2.2 Observation items: improvement of typical symptoms was observed. Typical symptoms are palpitation, shortness of breath, orthopnea, nocturnal paroxysmal dyspnea, compression or tightness pain behind the sternum, chest distress and discomfort, edema, cyanosis, syncope, cough and hemoptysis, weakness, eructation, epigastric pain, nausea and vomiting; left back pain, left arm pain.
3. Standard of therapeutic effect and therapeutic result
3.1 therapeutic criteria
The effect is shown: the symptoms of the cardiovascular and cerebrovascular diseases disappear, and the patients are recovered.
Improvement: the symptoms of cardiovascular and cerebrovascular diseases are obviously improved, and palpitation, shortness of breath, chest distress and edema are relieved and gradually return to normal.
And the invalid one can not reach the improvement standard.
3.2 treatment statistics see Table 1
TABLE 1 case treatment
Therefore, the medicine prepared by the preferred embodiment of the invention can safely and effectively treat the cardiovascular and cerebrovascular diseases.
According to the clinical test data, by combining the traditional Chinese medicine mechanism analysis for treating cardiovascular and cerebrovascular diseases and the common general knowledge in the field, the skilled person can easily deduce that the medicinal materials in the invention are selected within the conventional dosage range, namely, 8-12 parts of pilose antler, 15-25 parts of prepared rehmannia root, 10-20 parts of platycladi seed, 10-20 parts of Chinese magnoliavine fruit, 10-20 parts of Chinese angelica, 10-20 parts of szechuan lovage rhizome, 10-20 parts of figwort root, 10-20 parts of frankincense, 10-20 parts of honeysuckle flower, 10-20 parts of pseudo-ginseng, 10-20 parts of white paeony root, 10-20 parts of salvia miltiorrhiza, 10-20 parts of dendrobium, 10-20 parts of cape jasmine fruit and 10-20 parts of liquorice, so as to obtain the effect similar to that of the medicament prepared by the preferred embodiment of the invention.
Claims (6)
1. A traditional Chinese medicine medicament for treating cardiovascular and cerebrovascular diseases is characterized by comprising the following components in parts by weight: 8-12 parts of pilose antler, 15-25 parts of prepared rehmannia root, 10-20 parts of platycladi seed, 10-20 parts of Chinese magnoliavine fruit, 10-20 parts of Chinese angelica, 10-20 parts of ligusticum wallichii, 10-20 parts of figwort root, 10-20 parts of frankincense, 10-20 parts of honeysuckle flower, 10-20 parts of pseudo-ginseng, 10-20 parts of white paeony root, 10-20 parts of salvia miltiorrhiza, 10-20 parts of dendrobium, 10-20 parts of cape jasmine fruit and 10-20 parts of liquorice.
2. The traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases according to claim 1, which comprises the following components in parts by mass: 8-10 parts of pilose antler, 18-22 parts of prepared rehmannia root, 12-18 parts of platycladi seed, 12-18 parts of Chinese magnoliavine fruit, 12-18 parts of Chinese angelica, 12-18 parts of ligusticum wallichii, 12-18 parts of figwort root, 12-18 parts of frankincense, 12-18 parts of honeysuckle flower, 12-18 parts of pseudo-ginseng, 12-18 parts of white paeony root, 12-18 parts of salvia miltiorrhiza, 12-18 parts of dendrobium, 12-18 parts of cape jasmine fruit and 12-18 parts of liquorice.
3. The traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases according to claim 2, which comprises the following components in parts by mass: 10 parts of pilose antler, 20 parts of prepared rehmannia root, 15 parts of platycladi seed, 15 parts of Chinese magnoliavine fruit, 15 parts of Chinese angelica, 15 parts of ligusticum wallichii, 15 parts of figwort root, 15 parts of frankincense, 15 parts of honeysuckle, 15 parts of pseudo-ginseng, 15 parts of white paeony root, 15 parts of salvia miltiorrhiza, 15 parts of dendrobium, 15 parts of cape jasmine fruit and 15 parts of liquorice.
4. The preparation method of the traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases according to any one of claims 1 to 3, comprising the following steps:
(1) weighing the medicines according to the weight part ratio, and respectively drying the medicines;
(2) mixing and crushing the dried medicines, and sieving;
(3) adding honey into the medicinal powder, mixing, making into honeyed pill, and sealing for storage to obtain the Chinese medicinal preparation.
5. The method for preparing a Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases as claimed in claim 4, wherein the step (2) is carried out by sieving with 100-120 mesh sieve after pulverization.
6. The preparation method of the Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases according to claim 4, wherein the amount of honey in the step (3) is 30-40% of the total mass of the medicinal powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110223108.7A CN112933184A (en) | 2021-03-01 | 2021-03-01 | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110223108.7A CN112933184A (en) | 2021-03-01 | 2021-03-01 | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112933184A true CN112933184A (en) | 2021-06-11 |
Family
ID=76246779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110223108.7A Pending CN112933184A (en) | 2021-03-01 | 2021-03-01 | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112933184A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189714A (en) * | 2014-09-20 | 2014-12-10 | 田丽华 | Traditional Chinese medicine capsule for treating coronary heart disease |
| CN106581552A (en) * | 2015-10-20 | 2017-04-26 | 贵州瑞和制药有限公司龙里药厂 | Agent for treating coronary heart disease and preparation method of agent |
-
2021
- 2021-03-01 CN CN202110223108.7A patent/CN112933184A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189714A (en) * | 2014-09-20 | 2014-12-10 | 田丽华 | Traditional Chinese medicine capsule for treating coronary heart disease |
| CN106581552A (en) * | 2015-10-20 | 2017-04-26 | 贵州瑞和制药有限公司龙里药厂 | Agent for treating coronary heart disease and preparation method of agent |
Non-Patent Citations (3)
| Title |
|---|
| 周凌云等: "加味四妙勇安汤治疗气滞血瘀证慢性心力衰竭患者30例", 《中国实验方剂学杂志》 * |
| 方宇辉等: "金银花复方制剂对异丙肾上腺素诱发小鼠急性心肌缺血的影响", 《中国临床康复》 * |
| 赵新乡: "合理使用活血化瘀药治疗老年性心脑血管病", 《湖北中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103083400A (en) | Drug for treating cardiovascular disease | |
| CN101537160B (en) | Health product for toxicant elimination and beauty maintenance | |
| CN103893670B (en) | Traditional Chinese medicine pill used for treating cardia-cerebrovascular diseases | |
| CN111643605A (en) | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method | |
| CN101843889B (en) | Medicament for treating lymphedema and venous edema and application thereof | |
| CN112933184A (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN1123669A (en) | Capsule for protecting liver and eliminating tumor | |
| CN103251735A (en) | Chinese medicine for treating paroxysmal supraventricular tachycardia | |
| CN107281029A (en) | A kind of mask for acne powder | |
| CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
| CN100488526C (en) | Oral preparation | |
| CN109771567A (en) | A kind of formula of Chinese herbal medicine supporting vital QI and dispersing blood stasis toxin expelling tumour | |
| CN105012642B (en) | A kind of promoting blood circulation and removing blood stasis, preparation method of the Chinese medicine composition of hemostasis and pain-relieving | |
| CN102652768A (en) | Medicinal composition for relaxing tendons, activating collaterals, promoting blood circulation and removing blood stasis | |
| CN103127398B (en) | Chinese medicament for treating cancers and preparation method thereof | |
| CN102526449B (en) | Drug combination for treating coronary heart diseases caused by myocardial ischemia | |
| CN107854685A (en) | A kind of Chinese medicine composition with antitumor action and its production and use | |
| CN107496876A (en) | A kind of eliminating embolism and invigorating blood circulation Chinese medicine preparation and preparation method thereof | |
| CN109925399B (en) | Compound traditional Chinese medicine composition for treating coronary heart disease and angina pectoris and preparation method thereof | |
| CN117815354A (en) | Traditional Chinese medicine composition for dissolving thrombus and removing stasis and preparation method thereof | |
| CN105560911A (en) | Traditional Chinese medicine for treating hypertension and preparation method thereof | |
| CN105169014A (en) | Composition for treating vasculitis and preparation method | |
| CN1279959C (en) | Capsule for treating fibroma of mammary gland and preparation technique | |
| CN104998019A (en) | Traditional Chinese medicine composition for promoting blood circulation for removing blood stasis and reliving bleeding and pain | |
| CN112972581A (en) | Shenfeng heart-calming composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210611 |